Canadian Online Pharmacy

CDER New October 25, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

October 24, 2013


New and Generic Drug Approvals

October 23, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Adriamycin Pfs doxorubicin hydrochloride Injectable;Injection Pharmacia and Upjohn Manufacturing Change or Addition
Atripla efavirenz; emtricitabine; tenofovir disoproxil fumarate Tablet;Oral Gilead Labeling Revision
Complera emtricitabine; rilpivirine hydrochloride; tenofovir disoproxil fumarate Tablet;Oral Gilead Sciences Inc Labeling Revision
Kineret anakinra Vial; Subcutaneous Biovitrum Ab Labeling Revision
Lamisil terbinafine hydrochloride Tablet;Oral Novartis Labeling Revision
Lamisil terbinafine hydrochloride Granule;Oral Novartis Labeling Revision
Lovenox enoxaparin sodium Injectable;Intravenous, Subcutaneous Sanofi Aventis Us Labeling Revision
Lovenox (Preservative Free) enoxaparin sodium Injectable;Subcutaneous Sanofi Aventis Us Labeling Revision
Stribild cobicistat; elvitegravir; emtricitabine; tenofovir disoproxil fumarate Tablet;Oral Gilead Sciences Inc Labeling Revision
Suboxone buprenorphine hydrochloride; naloxone hydrochloride Tablet;Sublingual Reckitt Benckiser Manufacturing Change or Addition
Truvada emtricitabine; tenofovir disoproxil fumarate Tablet;Oral Gilead Labeling Revision
Viread tenofovir disoproxil fumarate Tablet;Oral Gilead Sciences Inc Labeling Revision
Viread tenofovir disoproxil fumarate Powder;Oral Gilead Sciences Inc Labeling Revision
Zyrtec-D 12 Hour cetirizine hydrochloride; pseudoephedrine hydrochloride Tablet, Extended Release;Oral Mcneil Manufacturing Change or Addition

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery